Neurogene Inc. Increase (Decrease) in Other Operating Assets
Neurogene Inc. (NGNE) reported Increase (Decrease) in Other Operating Assets of $74.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-11
- Neurogene Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $29.00K, a 85.50% decline year-over-year.
- Neurogene Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $45.00K.
- Neurogene Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$30.00K, a 116.13% decline year-over-year.
- Neurogene Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$33.00K.
- Neurogene Inc. increase (decrease) in other operating assets for fiscal 2025 was $58.00K, a 72.51% decline from fiscal 2024.
- Neurogene Inc. increase (decrease) in other operating assets for fiscal 2024 was $211.00K, a 72.38% decline from fiscal 2023.
- Neurogene Inc. increase (decrease) in other operating assets for fiscal 2023 was $764.00K.
- Neurogene Inc. increase (decrease) in other operating assets for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 3 month as first filed | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 6 month as first filed | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 9 month as first filed | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $74.00K 10-Q · filed 2026-08-11 | $44.00K derived: sum of 3 quarters · filed 2026-08-11 | $11.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $45.00K 10-Q · filed 2026-05-12 | $15.00K derived: sum of 2 quarters · filed 2026-05-12 | -$18.00K derived: sum of 3 quarters · filed 2026-05-12 | $182.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$63.00K derived: sum of 2 quarters · filed 2026-03-24 | $137.00K derived: sum of 3 quarters · filed 2026-08-11 | $58.00K 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $167.00K derived: sum of 2 quarters · filed 2026-08-11 | $88.00K 10-Q · filed 2025-11-13 | $274.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $121.00K 10-Q · filed 2026-08-11 | $307.00K derived: sum of 3 quarters · filed 2026-08-11 | $302.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | -$79.00K 10-Q · filed 2026-05-12 | $107.00K derived: sum of 2 quarters · filed 2026-05-12 | $102.00K derived: sum of 3 quarters · filed 2026-05-12 | $153.00K derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $181.00K derived: sum of 2 quarters · filed 2026-03-24 | $232.00K derived: sum of 3 quarters · filed 2026-03-24 | $211.00K 10-K · filed 2026-03-24 | ||||
| 2024-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $46.00K derived: sum of 2 quarters · filed 2025-11-13 | $25.00K 10-Q · filed 2025-11-13 | $789.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $30.00K 10-Q · filed 2025-08-11 | $794.00K derived: sum of 3 quarters · filed 2025-08-11 | $794.00K derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | -$21.00K 10-Q · filed 2025-05-09 | $743.00K derived: sum of 2 quarters · filed 2025-05-09 | $743.00K derived: sum of 3 quarters · filed 2025-05-09 | $743.00K derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | $764.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $764.00K derived: sum of 2 quarters · filed 2025-03-24 | $764.00K derived: sum of 3 quarters · filed 2025-03-24 | $764.00K 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | $0.00 derived: sum of 2 quarters · filed 2024-11-18 | $0.00 10-Q · filed 2024-11-18 | -$1.38M 10-Q · filed 2023-11-14 | -$287.00K derived: sum of 4 quarters · filed 2024-11-18 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | -$1.05M 10-Q · filed 2023-08-10 | -$287.00K derived: sum of 3 quarters · filed 2024-08-09 | -$537.00K derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 | -$552.00K 10-Q · filed 2023-05-08 | -$287.00K derived: sum of 2 quarters · filed 2024-05-10 | -$537.00K derived: sum of 3 quarters · filed 2024-05-10 | -$803.00K derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | -$287.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$537.00K derived: sum of 2 quarters · filed 2024-03-18 | -$803.00K derived: sum of 3 quarters · filed 2024-03-18 | $0.00 10-K · filed 2024-03-18 | $206.00K 10-K · filed 2023-03-20 | |||
| 2022-09-30 | -$250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$516.00K derived: sum of 2 quarters · filed 2023-11-14 | $287.00K 10-Q · filed 2023-11-14 | $194.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$266.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $537.00K 10-Q · filed 2023-08-10 | $444.00K derived: sum of 3 quarters · filed 2023-08-10 | -$1.21M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $803.00K 10-Q · filed 2023-05-08 | $710.00K derived: sum of 2 quarters · filed 2023-05-08 | -$940.00K derived: sum of 3 quarters · filed 2023-05-08 | -$139.00K derived: sum of 4 quarters · filed 2023-05-08 | ||||
| 2021-12-31 | -$93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$1.74M derived: sum of 2 quarters · filed 2023-03-20 | -$942.00K derived: sum of 3 quarters · filed 2023-03-20 | -$129.00K 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | -$1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$849.00K derived: sum of 2 quarters · filed 2022-11-14 | -$36.00K 10-Q · filed 2022-11-14 | -$2.58M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $801.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.61M 10-Q · filed 2022-08-09 | -$931.00K derived: sum of 3 quarters · filed 2022-08-09 | $3.23M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $813.00K 10-Q · filed 2022-05-09 | -$1.73M derived: sum of 2 quarters · filed 2022-05-09 | $2.42M derived: sum of 3 quarters · filed 2022-05-09 | $3.56M derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | -$2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.61M derived: sum of 2 quarters · filed 2022-03-01 | $2.75M derived: sum of 3 quarters · filed 2022-03-01 | $2.48M 10-K · filed 2022-03-01 | ||||
| 2020-09-30 | $4.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $5.29M derived: sum of 2 quarters · filed 2021-11-04 | $5.03M 10-Q · filed 2021-11-04 | $4.28M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $870.00K 10-Q · filed 2021-08-05 | $127.00K derived: sum of 3 quarters · filed 2021-08-05 | $334.00K derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$266.00K 10-Q · filed 2021-05-12 | -$1.01M derived: sum of 2 quarters · filed 2021-05-12 | -$802.00K derived: sum of 3 quarters · filed 2021-05-12 | |||||
| 2019-12-31 | -$743.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$536.00K derived: sum of 2 quarters · filed 2021-03-25 | -$290.00K 10-K · filed 2021-03-25 | |||||
| 2019-09-30 | $207.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $453.00K 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | $246.00K 10-Q · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |